Structure

Physi-Chem Properties

Molecular Weight:  606.27
Volume:  623.154
LogP:  6.125
LogD:  3.751
LogS:  -5.965
# Rotatable Bonds:  2
TPSA:  72.86
# H-Bond Aceptor:  8
# H-Bond Donor:  1
# Rings:  9
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.269
Synthetic Accessibility Score:  5.959
Fsp3:  0.351
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.879
MDCK Permeability:  2.1726456907344982e-05
Pgp-inhibitor:  0.998
Pgp-substrate:  0.308
Human Intestinal Absorption (HIA):  0.016
20% Bioavailability (F20%):  0.005
30% Bioavailability (F30%):  0.985

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.473
Plasma Protein Binding (PPB):  94.06542205810547%
Volume Distribution (VD):  1.042
Pgp-substrate:  5.689208507537842%

ADMET: Metabolism

CYP1A2-inhibitor:  0.065
CYP1A2-substrate:  0.94
CYP2C19-inhibitor:  0.056
CYP2C19-substrate:  0.952
CYP2C9-inhibitor:  0.031
CYP2C9-substrate:  0.458
CYP2D6-inhibitor:  0.008
CYP2D6-substrate:  0.954
CYP3A4-inhibitor:  0.053
CYP3A4-substrate:  0.95

ADMET: Excretion

Clearance (CL):  8.512
Half-life (T1/2):  0.337

ADMET: Toxicity

hERG Blockers:  0.916
Human Hepatotoxicity (H-HT):  0.026
Drug-inuced Liver Injury (DILI):  0.263
AMES Toxicity:  0.172
Rat Oral Acute Toxicity:  0.261
Maximum Recommended Daily Dose:  0.995
Skin Sensitization:  0.791
Carcinogencity:  0.047
Eye Corrosion:  0.003
Eye Irritation:  0.004
Respiratory Toxicity:  0.432

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC206900

Natural Product ID:  NPC206900
Common Name*:   Racemosidine A
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  CQWDLZVYIHGYLN-VSGBNLITSA-N
Standard InCHI:  InChI=1S/C37H38N2O6/c1-38-11-9-23-17-32(41-3)33-19-26(23)27(38)14-21-6-8-30-25(13-21)20-43-36-34(42-4)18-24-10-12-39(2)28(35(24)37(36)45-30)15-22-5-7-29(40)31(16-22)44-33/h5-8,13,16-19,27-28,40H,9-12,14-15,20H2,1-4H3/t27-,28-/m1/s1
SMILES:  COc1cc2CCN([C@H]3c2cc1Oc1cc(ccc1O)C[C@H]1N(C)CCc2c1c1Oc4ccc(C3)cc4COc1c(c2)OC)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1172568
PubChem CID:   46872237
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000254] Ethers
          • [CHEMONTID:0002463] Diarylethers

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO18410 Cyclea racemosa Species Menispermaceae Eukaryota roots n.a. n.a. PMID[20593839]
NPO18410 Cyclea racemosa Species Menispermaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO18410 Cyclea racemosa Species Menispermaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO18410 Cyclea racemosa Species Menispermaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO18410 Cyclea racemosa Species Menispermaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT180 Cell Line HCT-8 Homo sapiens IC50 = 2800.0 nM PMID[465863]
NPT181 Cell Line Bel-7402 Homo sapiens IC50 = 6090.0 nM PMID[465863]
NPT179 Cell Line A2780 Homo sapiens IC50 = 6700.0 nM PMID[465863]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC206900 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9708 High Similarity NPC275680
0.9708 High Similarity NPC22115
0.9704 High Similarity NPC185639
0.9704 High Similarity NPC328155
0.9704 High Similarity NPC104196
0.9704 High Similarity NPC290582
0.9704 High Similarity NPC271013
0.9704 High Similarity NPC222661
0.9704 High Similarity NPC311973
0.9704 High Similarity NPC182052
0.9704 High Similarity NPC251735
0.9704 High Similarity NPC279228
0.9704 High Similarity NPC7715
0.9704 High Similarity NPC54654
0.9704 High Similarity NPC49075
0.9704 High Similarity NPC42663
0.9704 High Similarity NPC239824
0.9704 High Similarity NPC90998
0.9704 High Similarity NPC229373
0.9704 High Similarity NPC223690
0.9704 High Similarity NPC217748
0.9704 High Similarity NPC15414
0.9704 High Similarity NPC290005
0.9704 High Similarity NPC181796
0.9704 High Similarity NPC285931
0.9704 High Similarity NPC8836
0.9704 High Similarity NPC258657
0.9647 High Similarity NPC274716
0.9647 High Similarity NPC254441
0.9647 High Similarity NPC167116
0.9645 High Similarity NPC286119
0.9591 High Similarity NPC302245
0.9591 High Similarity NPC95426
0.9591 High Similarity NPC16357
0.9588 High Similarity NPC30779
0.9535 High Similarity NPC65312
0.9535 High Similarity NPC139783
0.9535 High Similarity NPC116465
0.9535 High Similarity NPC212237
0.9429 High Similarity NPC478093
0.9425 High Similarity NPC175890
0.9425 High Similarity NPC11296
0.9425 High Similarity NPC48490
0.9425 High Similarity NPC82457
0.9425 High Similarity NPC274661
0.9375 High Similarity NPC473589
0.9375 High Similarity NPC478091
0.9375 High Similarity NPC478092
0.9375 High Similarity NPC30182
0.9371 High Similarity NPC191132
0.9371 High Similarity NPC60295
0.9318 High Similarity NPC24260
0.929 High Similarity NPC115284
0.929 High Similarity NPC317439
0.929 High Similarity NPC76682
0.929 High Similarity NPC276890
0.929 High Similarity NPC227060
0.929 High Similarity NPC63646
0.929 High Similarity NPC10908
0.929 High Similarity NPC317145
0.929 High Similarity NPC198498
0.9266 High Similarity NPC256124
0.9235 High Similarity NPC129518
0.9235 High Similarity NPC41376
0.9235 High Similarity NPC12424
0.9235 High Similarity NPC251580
0.9172 High Similarity NPC83198
0.9172 High Similarity NPC204908
0.9128 High Similarity NPC293093
0.9056 High Similarity NPC234318
0.9053 High Similarity NPC250846
0.9053 High Similarity NPC268503
0.9053 High Similarity NPC264850
0.9053 High Similarity NPC42549
0.9053 High Similarity NPC13916
0.9053 High Similarity NPC256012
0.9053 High Similarity NPC317272
0.9053 High Similarity NPC240841
0.905 High Similarity NPC85381
0.9045 High Similarity NPC41122
0.9045 High Similarity NPC318805
0.9023 High Similarity NPC475479
0.9023 High Similarity NPC243454
0.9012 High Similarity NPC152680
0.9012 High Similarity NPC232386
0.9012 High Similarity NPC190783
0.9011 High Similarity NPC475654
0.8994 High Similarity NPC24465
0.8977 High Similarity NPC302275
0.8971 High Similarity NPC239584
0.892 High Similarity NPC299990
0.892 High Similarity NPC73492
0.8865 High Similarity NPC254581
0.8771 High Similarity NPC14507
0.8771 High Similarity NPC47077
0.8736 High Similarity NPC239775
0.8736 High Similarity NPC475215
0.8736 High Similarity NPC108434
0.8715 High Similarity NPC249996
0.8678 High Similarity NPC168753
0.8678 High Similarity NPC118274
0.8674 High Similarity NPC281581
0.8652 High Similarity NPC195538
0.8639 High Similarity NPC247639
0.8639 High Similarity NPC25084
0.8626 High Similarity NPC475597
0.8626 High Similarity NPC473716
0.8603 High Similarity NPC476202
0.858 High Similarity NPC469817
0.858 High Similarity NPC172765
0.858 High Similarity NPC39701
0.858 High Similarity NPC204828
0.858 High Similarity NPC276588
0.858 High Similarity NPC2413
0.858 High Similarity NPC249797
0.858 High Similarity NPC127674
0.858 High Similarity NPC110416
0.858 High Similarity NPC184026
0.858 High Similarity NPC54379
0.858 High Similarity NPC189266
0.858 High Similarity NPC295691
0.858 High Similarity NPC5238
0.858 High Similarity NPC207757
0.858 High Similarity NPC278799
0.858 High Similarity NPC193949
0.8564 High Similarity NPC82056
0.8547 High Similarity NPC60186
0.8492 Intermediate Similarity NPC32154
0.8492 Intermediate Similarity NPC474507
0.8488 Intermediate Similarity NPC271388
0.8488 Intermediate Similarity NPC205255
0.8488 Intermediate Similarity NPC235143
0.8488 Intermediate Similarity NPC119649
0.8488 Intermediate Similarity NPC230956
0.8462 Intermediate Similarity NPC38964
0.8457 Intermediate Similarity NPC474931
0.8457 Intermediate Similarity NPC145832
0.8457 Intermediate Similarity NPC158376
0.8457 Intermediate Similarity NPC306555
0.8457 Intermediate Similarity NPC117188
0.8457 Intermediate Similarity NPC81218
0.8457 Intermediate Similarity NPC205421
0.8457 Intermediate Similarity NPC12053
0.8448 Intermediate Similarity NPC13504
0.8448 Intermediate Similarity NPC306843
0.8448 Intermediate Similarity NPC253043
0.8448 Intermediate Similarity NPC136508
0.8448 Intermediate Similarity NPC196447
0.8448 Intermediate Similarity NPC78222
0.8448 Intermediate Similarity NPC96603
0.8448 Intermediate Similarity NPC212794
0.8448 Intermediate Similarity NPC477563
0.8444 Intermediate Similarity NPC230276
0.8444 Intermediate Similarity NPC257269
0.8439 Intermediate Similarity NPC79402
0.8439 Intermediate Similarity NPC80759
0.843 Intermediate Similarity NPC221864
0.8418 Intermediate Similarity NPC10871
0.8391 Intermediate Similarity NPC475393
0.8391 Intermediate Similarity NPC324144
0.8389 Intermediate Similarity NPC40496
0.8389 Intermediate Similarity NPC119068
0.838 Intermediate Similarity NPC476577
0.838 Intermediate Similarity NPC173416
0.838 Intermediate Similarity NPC241704
0.838 Intermediate Similarity NPC148709
0.8343 Intermediate Similarity NPC97221
0.8343 Intermediate Similarity NPC220858
0.8343 Intermediate Similarity NPC88249
0.8343 Intermediate Similarity NPC151895
0.8343 Intermediate Similarity NPC192768
0.8286 Intermediate Similarity NPC1229
0.8284 Intermediate Similarity NPC103379
0.8284 Intermediate Similarity NPC477565
0.8276 Intermediate Similarity NPC166014
0.8276 Intermediate Similarity NPC27410
0.8256 Intermediate Similarity NPC123323
0.8239 Intermediate Similarity NPC232514
0.8239 Intermediate Similarity NPC238530
0.8239 Intermediate Similarity NPC276944
0.8239 Intermediate Similarity NPC169743
0.8225 Intermediate Similarity NPC428
0.8225 Intermediate Similarity NPC24233
0.8225 Intermediate Similarity NPC147390
0.8225 Intermediate Similarity NPC476571
0.8225 Intermediate Similarity NPC135538
0.8225 Intermediate Similarity NPC246587
0.8192 Intermediate Similarity NPC223077
0.8192 Intermediate Similarity NPC56887
0.8192 Intermediate Similarity NPC124657
0.8192 Intermediate Similarity NPC193853
0.8172 Intermediate Similarity NPC82763
0.8167 Intermediate Similarity NPC66341
0.8167 Intermediate Similarity NPC477020
0.8167 Intermediate Similarity NPC192135
0.8166 Intermediate Similarity NPC476151
0.8166 Intermediate Similarity NPC321505
0.8166 Intermediate Similarity NPC106295
0.8166 Intermediate Similarity NPC16107
0.8166 Intermediate Similarity NPC476144

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC206900 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9704 High Similarity NPD8053 Approved
0.9704 High Similarity NPD8054 Approved
0.9349 High Similarity NPD8156 Discontinued
0.929 High Similarity NPD8099 Discontinued
0.929 High Similarity NPD8251 Approved
0.929 High Similarity NPD8252 Approved
0.8389 Intermediate Similarity NPD8453 Clinical (unspecified phase)
0.8351 Intermediate Similarity NPD8095 Phase 1
0.8166 Intermediate Similarity NPD4584 Approved
0.8162 Intermediate Similarity NPD7906 Approved
0.8114 Intermediate Similarity NPD6788 Approved
0.809 Intermediate Similarity NPD6071 Discontinued
0.7989 Intermediate Similarity NPD4772 Phase 2
0.7989 Intermediate Similarity NPD4773 Phase 2
0.7966 Intermediate Similarity NPD7832 Clinical (unspecified phase)
0.7966 Intermediate Similarity NPD7831 Phase 2
0.7966 Intermediate Similarity NPD7833 Phase 2
0.7946 Intermediate Similarity NPD7313 Approved
0.7946 Intermediate Similarity NPD7312 Approved
0.7946 Intermediate Similarity NPD7310 Approved
0.7946 Intermediate Similarity NPD7311 Approved
0.7906 Intermediate Similarity NPD7667 Clinical (unspecified phase)
0.7903 Intermediate Similarity NPD7309 Approved
0.7901 Intermediate Similarity NPD27 Approved
0.7901 Intermediate Similarity NPD2489 Approved
0.7898 Intermediate Similarity NPD6818 Clinical (unspecified phase)
0.7889 Intermediate Similarity NPD3051 Approved
0.7853 Intermediate Similarity NPD2560 Approved
0.7853 Intermediate Similarity NPD2563 Approved
0.7849 Intermediate Similarity NPD4578 Approved
0.7849 Intermediate Similarity NPD4577 Approved
0.7845 Intermediate Similarity NPD2969 Approved
0.7845 Intermediate Similarity NPD2970 Approved
0.7819 Intermediate Similarity NPD4663 Approved
0.7811 Intermediate Similarity NPD4664 Clinical (unspecified phase)
0.7746 Intermediate Similarity NPD1754 Clinical (unspecified phase)
0.7746 Intermediate Similarity NPD7447 Phase 1
0.774 Intermediate Similarity NPD7298 Approved
0.767 Intermediate Similarity NPD7261 Clinical (unspecified phase)
0.7609 Intermediate Similarity NPD2898 Approved
0.7606 Intermediate Similarity NPD7549 Discontinued
0.7586 Intermediate Similarity NPD2420 Approved
0.7586 Intermediate Similarity NPD2421 Approved
0.7586 Intermediate Similarity NPD7213 Phase 3
0.7586 Intermediate Similarity NPD7212 Phase 2
0.7582 Intermediate Similarity NPD7201 Clinical (unspecified phase)
0.7529 Intermediate Similarity NPD6029 Clinical (unspecified phase)
0.7529 Intermediate Similarity NPD6028 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD4581 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD4010 Discontinued
0.7473 Intermediate Similarity NPD4055 Discovery
0.7471 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7458 Intermediate Similarity NPD6031 Approved
0.7458 Intermediate Similarity NPD6030 Approved
0.7443 Intermediate Similarity NPD1424 Approved
0.7437 Intermediate Similarity NPD2494 Approved
0.7437 Intermediate Similarity NPD3450 Approved
0.7437 Intermediate Similarity NPD2493 Approved
0.7437 Intermediate Similarity NPD3452 Approved
0.743 Intermediate Similarity NPD4678 Approved
0.743 Intermediate Similarity NPD4675 Approved
0.7429 Intermediate Similarity NPD3845 Phase 1
0.7423 Intermediate Similarity NPD2488 Approved
0.7423 Intermediate Similarity NPD2490 Approved
0.7419 Intermediate Similarity NPD4481 Phase 3
0.7414 Intermediate Similarity NPD6748 Discontinued
0.7389 Intermediate Similarity NPD6072 Discontinued
0.7371 Intermediate Similarity NPD5241 Discontinued
0.7351 Intermediate Similarity NPD6107 Approved
0.7346 Intermediate Similarity NPD6997 Phase 2
0.7344 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.733 Intermediate Similarity NPD7124 Phase 2
0.7327 Intermediate Similarity NPD4583 Approved
0.7327 Intermediate Similarity NPD4582 Approved
0.7321 Intermediate Similarity NPD8153 Approved
0.7321 Intermediate Similarity NPD8152 Approved
0.7308 Intermediate Similarity NPD7047 Phase 3
0.7303 Intermediate Similarity NPD6090 Discontinued
0.73 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7297 Intermediate Similarity NPD5677 Discontinued
0.7288 Intermediate Similarity NPD7598 Phase 2
0.7278 Intermediate Similarity NPD4017 Approved
0.7278 Intermediate Similarity NPD4005 Discontinued
0.7277 Intermediate Similarity NPD4004 Approved
0.7277 Intermediate Similarity NPD4002 Approved
0.7263 Intermediate Similarity NPD3641 Approved
0.7263 Intermediate Similarity NPD3639 Approved
0.7263 Intermediate Similarity NPD3640 Phase 3
0.7258 Intermediate Similarity NPD7802 Discontinued
0.7236 Intermediate Similarity NPD2974 Approved
0.7236 Intermediate Similarity NPD2973 Approved
0.7236 Intermediate Similarity NPD2975 Approved
0.7235 Intermediate Similarity NPD4475 Approved
0.7235 Intermediate Similarity NPD4474 Approved
0.7213 Intermediate Similarity NPD5773 Approved
0.7213 Intermediate Similarity NPD5772 Approved
0.7211 Intermediate Similarity NPD42 Phase 2
0.7211 Intermediate Similarity NPD6042 Phase 2
0.7189 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7168 Intermediate Similarity NPD7718 Clinical (unspecified phase)
0.7168 Intermediate Similarity NPD2200 Suspended
0.7167 Intermediate Similarity NPD2122 Discontinued
0.7164 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7163 Intermediate Similarity NPD7827 Phase 1
0.716 Intermediate Similarity NPD5752 Clinical (unspecified phase)
0.7159 Intermediate Similarity NPD5177 Phase 3
0.7151 Intermediate Similarity NPD4123 Phase 3
0.7143 Intermediate Similarity NPD5005 Approved
0.7143 Intermediate Similarity NPD5006 Approved
0.7135 Intermediate Similarity NPD6666 Approved
0.7135 Intermediate Similarity NPD6667 Approved
0.7135 Intermediate Similarity NPD2422 Clinical (unspecified phase)
0.7129 Intermediate Similarity NPD4580 Approved
0.712 Intermediate Similarity NPD5312 Approved
0.712 Intermediate Similarity NPD4873 Discontinued
0.712 Intermediate Similarity NPD5313 Approved
0.712 Intermediate Similarity NPD7046 Clinical (unspecified phase)
0.7119 Intermediate Similarity NPD7466 Approved
0.7113 Intermediate Similarity NPD2968 Approved
0.7113 Intermediate Similarity NPD2971 Approved
0.7093 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7093 Intermediate Similarity NPD1613 Approved
0.7088 Intermediate Similarity NPD6523 Clinical (unspecified phase)
0.7088 Intermediate Similarity NPD8158 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD1632 Clinical (unspecified phase)
0.7077 Intermediate Similarity NPD6853 Approved
0.7077 Intermediate Similarity NPD6851 Approved
0.7076 Intermediate Similarity NPD5718 Phase 2
0.7073 Intermediate Similarity NPD4040 Phase 1
0.7072 Intermediate Similarity NPD7427 Discontinued
0.7068 Intermediate Similarity NPD7493 Clinical (unspecified phase)
0.7065 Intermediate Similarity NPD7945 Clinical (unspecified phase)
0.7062 Intermediate Similarity NPD7132 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD4908 Phase 1
0.7056 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.7047 Intermediate Similarity NPD6996 Clinical (unspecified phase)
0.7026 Intermediate Similarity NPD3534 Clinical (unspecified phase)
0.7021 Intermediate Similarity NPD4666 Phase 3
0.7006 Intermediate Similarity NPD7037 Approved
0.7006 Intermediate Similarity NPD7045 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD3124 Discontinued
0.6995 Remote Similarity NPD3837 Clinical (unspecified phase)
0.6983 Remote Similarity NPD3692 Discontinued
0.698 Remote Similarity NPD6621 Clinical (unspecified phase)
0.6978 Remote Similarity NPD5976 Discontinued
0.6974 Remote Similarity NPD4419 Clinical (unspecified phase)
0.6968 Remote Similarity NPD5709 Phase 3
0.6966 Remote Similarity NPD3060 Approved
0.6966 Remote Similarity NPD4236 Phase 3
0.6966 Remote Similarity NPD4237 Approved
0.6966 Remote Similarity NPD4162 Approved
0.6959 Remote Similarity NPD6297 Approved
0.6949 Remote Similarity NPD2029 Clinical (unspecified phase)
0.6946 Remote Similarity NPD4420 Approved
0.6944 Remote Similarity NPD6783 Clinical (unspecified phase)
0.6935 Remote Similarity NPD2977 Approved
0.6935 Remote Similarity NPD4585 Approved
0.6935 Remote Similarity NPD2978 Approved
0.6927 Remote Similarity NPD5602 Clinical (unspecified phase)
0.6927 Remote Similarity NPD5938 Phase 3
0.6923 Remote Similarity NPD5261 Clinical (unspecified phase)
0.6919 Remote Similarity NPD5090 Approved
0.6919 Remote Similarity NPD3027 Phase 3
0.6919 Remote Similarity NPD5089 Approved
0.6915 Remote Similarity NPD8005 Clinical (unspecified phase)
0.6911 Remote Similarity NPD8051 Clinical (unspecified phase)
0.6907 Remote Similarity NPD7479 Phase 2
0.6898 Remote Similarity NPD7907 Approved
0.6897 Remote Similarity NPD6284 Clinical (unspecified phase)
0.6897 Remote Similarity NPD2238 Phase 2
0.6893 Remote Similarity NPD7590 Clinical (unspecified phase)
0.6892 Remote Similarity NPD6723 Discontinued
0.6889 Remote Similarity NPD5084 Clinical (unspecified phase)
0.6889 Remote Similarity NPD2677 Approved
0.6889 Remote Similarity NPD5160 Discontinued
0.6884 Remote Similarity NPD6841 Approved
0.6884 Remote Similarity NPD6843 Phase 3
0.6884 Remote Similarity NPD7291 Discontinued
0.6884 Remote Similarity NPD6842 Approved
0.6879 Remote Similarity NPD6812 Clinical (unspecified phase)
0.6875 Remote Similarity NPD6111 Discontinued
0.6875 Remote Similarity NPD6896 Approved
0.6875 Remote Similarity NPD6895 Approved
0.6872 Remote Similarity NPD6496 Clinical (unspecified phase)
0.6868 Remote Similarity NPD7019 Approved
0.6868 Remote Similarity NPD7020 Approved
0.6862 Remote Similarity NPD7773 Phase 2
0.6859 Remote Similarity NPD4166 Phase 2
0.6854 Remote Similarity NPD7030 Discontinued
0.685 Remote Similarity NPD6377 Clinical (unspecified phase)
0.6842 Remote Similarity NPD2904 Discontinued
0.6842 Remote Similarity NPD3365 Discontinued
0.6839 Remote Similarity NPD2674 Phase 3
0.6836 Remote Similarity NPD1753 Discontinued
0.6833 Remote Similarity NPD6331 Phase 2
0.6833 Remote Similarity NPD6658 Clinical (unspecified phase)
0.6832 Remote Similarity NPD7262 Phase 1

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data